Agilent Technologies SureSelect target enrichment for Ion Proton next-generation sequencing systems

Agilent Technologies has introduced a SureSelect target enrichment product that allows Ion Proton users to realise the full power of their next-generation sequencers with human exome and custom DNA target enrichment solutions. SureSelect target enrichment is now available for all major sequencing platforms, enabling researchers to achieve high-performance target enrichment results with a variety of sequencers.

Already used extensively with high-throughput and desktop sequencers, the products yield high sensitivity and specificity with a fast, easy workflow, generating sequencer-ready samples in only 1.5 days. Other distinctive features include highly uniform sequencing coverage, with more than 99% SNP concordance rates. The product’s flexibility also enables researchers to easily create custom panels specific to their targets of interest with SureDesign, Agilent’s user-friendly online design software.

The SureSelect Human All Exon V5 human exome kit is now available for Ion Proton researchers using the SureSelect TE Reagent Kit for Ion Proton.